Vaccination

Swiss say more data needed on AstraZeneca jab

Swiss regulators said Wednesday that data submitted by AstraZeneca were not yet sufficient for it to authorise use of the Anglo-Swedish firm's COVID-19 vaccine and "new studies" were needed.

Vaccination

Swiss sign off on Moderna as 2nd COVID vaccine

Switzerland gave the green light Tuesday to the Moderna vaccine against the new coronavirus—after being the first country in continental Europe to start using the Pfizer-BioNTech jab.

Diseases, Conditions, Syndromes

Antibodies needed to save lives in Africa

Scientific advances have transformed the prevention, treatment and cure of many diseases globally. However, millions of Africans continue to die, endure long periods of illnesses—and suffer negative impacts of diseases ...

Diseases, Conditions, Syndromes

What to expect from a COVID-19 vaccine

One of the hottest topics around COVID-19 is the need for a vaccine for this new disease, which has had a huge impact on both human health and economies. The disease caught most people completely by surprise and shows no ...

Diseases, Conditions, Syndromes

Guideline issued for nonsevere, severe COVID-19 therapy

(HealthDay)—In an evidence-based guideline developed by an international team of physicians, pharmacists, researchers, and patients, published online April 29 in CMAJ, the journal of the Canadian Medical Association, recommendations ...

Diseases, Conditions, Syndromes

Pharma chiefs expect coronavirus vaccine in 12-18 months

The pharmaceutical industry expects it will take 12 to 18 months to roll out a coronavirus vaccine, executives said Thursday, as they jointly pledged to make it available worldwide based on need.

page 1 from 3